WO2022206083A1 - Miniature in-vivo robot device, and optimal treatment regulation and control system and method - Google Patents

Miniature in-vivo robot device, and optimal treatment regulation and control system and method Download PDF

Info

Publication number
WO2022206083A1
WO2022206083A1 PCT/CN2022/000044 CN2022000044W WO2022206083A1 WO 2022206083 A1 WO2022206083 A1 WO 2022206083A1 CN 2022000044 W CN2022000044 W CN 2022000044W WO 2022206083 A1 WO2022206083 A1 WO 2022206083A1
Authority
WO
WIPO (PCT)
Prior art keywords
vivo
micro
treatment
drug
robot
Prior art date
Application number
PCT/CN2022/000044
Other languages
French (fr)
Chinese (zh)
Inventor
谈斯聪
于皓
于梦非
谈勇学
于志英
Original Assignee
谈斯聪
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 谈斯聪 filed Critical 谈斯聪
Priority to AU2022252507A priority Critical patent/AU2022252507A1/en
Priority to CN202280024177.8A priority patent/CN117545443A/en
Publication of WO2022206083A1 publication Critical patent/WO2022206083A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041Capsule endoscopes for imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00131Accessories for endoscopes
    • A61B1/00133Drive units for endoscopic tools inserted through or with the endoscope
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147Holding or positioning arrangements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147Holding or positioning arrangements
    • A61B1/00158Holding or positioning arrangements using magnetic field
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/045Control thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/06Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements
    • A61B1/0661Endoscope light sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/007Injectors for solid bodies, e.g. suppositories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007Arrangements or means for the introduction of sources into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103Treatment planning systems
    • A61N5/1031Treatment planning systems using a specific method of dose optimization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00345Micromachines, nanomachines, microsystems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/587Lighting arrangements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019Sources therefor
    • A61N2005/1021Radioactive fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019Sources therefor
    • A61N2005/1024Seeds

Definitions

  • the invention belongs to the technical field of artificial intelligence robot health medical equipment, and relates to micro-robot technology, artificial intelligence image intelligent recognition, remote control, and optimization related theories and technical fields.
  • the in-vivo vision device and the in-vitro imaging device realize high-precision acquisition of in-vivo images, intelligently identify dual images, and assist in identifying damaged tissues, tumors and locating their positions in the body. Double-accurate identification of human organs, damaged tissues, high-precision identification of normal areas and damaged areas.
  • Multi-sensing module for real-time monitoring of in vivo body environment.
  • Micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize micro cutting suture, puncture, cautery, laser cutting, targeted therapy.
  • the multi-objective optimization of comprehensive indicators can be achieved, the drug and its quantification can be controlled, and the optimal regulation of the disease in vivo can be achieved.
  • the purpose of the present invention is to overcome the above-mentioned shortcomings and deficiencies of the prior art, and to provide a micro-robot device for use in the body, which can be non-invasively delivered into the body through magnetic guidance, thereby reducing the risk of extracorporeal surgery.
  • Dual imaging devices intelligently identify diseases and reduce human errors in diagnosis and treatment. Sensors collect data in real time, optimize drug delivery, monitor in vivo data in real time, track the effect of in vivo treatment in real time, dynamically adjust and optimize in vivo drugs, drug dosage, precise drug administration, and efficiently solve problems such as tumors and tissue damage.
  • the invention provides a remote control for administrators, which can accurately locate damaged tissue through in-vivo imaging of a camera and an in-vitro imaging guide device, accurately divide the damaged tissue area and the normal tissue area, and implement treatment according to the degree of damage.
  • the invention also provides A high-precision organ, double-accurate positioning of damaged tissue, and double-accurate identification method.
  • the present invention also provides a method for determining and quantifying a drug using an optimized method, an optimized dosing planning method for radiopharmaceuticals, realizing multi-objective optimization of comprehensive indicators, regulating drugs and their quantification, and realizing optimal regulation of in vivo conditions. Also provided is a high-precision positioning, remote-controlled non-invasive in vivo surgical method and a remote and autonomous drug delivery method.
  • an in-vivo micro-robot device an optimized treatment regulation system and method, is characterized in that, an in-vivo micro-robot device comprises:
  • the in vivo micro-robot device includes: visual recognition module, multi-sensing module, lighting device, in-vivo walking drive device, puncture device, retractable puncture needle, pressure device, surgical inspection processing device, ultrasonic microelectrode array, micro ultrasonic probe device, particle implant Insertion device, stent, soft stent, fixation device, precise drug delivery device.
  • the in vitro imaging device is used for in vitro imaging, including one of various imaging methods such as ultrasound imaging, CT imaging, and X-ray imaging.
  • the miniature camera and visual recognition module in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
  • the multi-sensing module includes: one or more of a variety of sensors such as miniature biosensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
  • the driving device is used to drive the robot to swim in a non-damaged, speed-controlled and directional manner in the body.
  • the guiding, positioning, and moving device is connected with the in vitro imaging device, and the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in-vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in-vivo micro-robot to locate the damaged tissue and tumor in the body.
  • Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices.
  • Soft stent, fixation device used for swimming in the body, temporary stop, damaged tissue, and fixation of tumor location during surgical treatment.
  • Retractable in-vivo inspection and surgical treatment devices including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device.
  • micro forceps including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device.
  • Retractable and precise drug delivery device used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
  • the body is moved and positioned by electromagnetic, radio frequency, magnetic and other guiding devices, reducing the high risk of external surgical trauma, and achieving basic non-invasive, internal inspection, surgery, and efficient realization In vivo real-time monitoring, optimal control of in vivo conditions.
  • Dual-accurate imaging methods using the in-vivo camera and visual recognition module of the miniature camera to work together with the in-vitro imaging device, high-precision acquisition, assisting in identifying images of organs, damaged tissues, tumors, etc., and accurately identifying damaged tissues and normal tissue areas.
  • the in-vivo camera and visual recognition module are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
  • the visual recognition module includes: one or more of in vivo imaging devices such as a micro endoscope and a micro microscope, and a 3D imaging system cooperates with an in vitro imaging guide device to collect and intelligently identify images of various diseases in the body.
  • the driving device drives the robot to swim without damage in the body, with controllable speed and direction.
  • Use soft stents and fixation devices to temporarily fix, assist in-vivo robots to perform surgery, check damaged tissue, etc. to complete in-vivo treatment.
  • the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in vivo micro-robot to locate the damaged tissue and tumor in the body.
  • driving device used to drive the micro robot to move, walk and swim in the body.
  • the driving device includes one of current driving, electromagnetic driving and magnetic driving.
  • Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices. Soft stent, fixation device, used for in vivo tissue examination, damaged tissue, fixation during surgical treatment of tumor location.
  • the multi-sensing module monitors the in vivo environment in real time.
  • Multi-sensing includes: one or more of various sensors such as micro bio-sensing, micro-medical sensing, and comprehensive gene sensing, which are used to collect sensor information in vivo and monitor the in-vivo environment in real time.
  • the in vivo environment includes: the in vivo immune environment and the tumor treatment microenvironment, and the in vivo environment during monitoring.
  • Surgical inspection and processing devices including: one or more of micro forceps, micro forceps, puncture retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, and laser devices.
  • puncture surgical operation.
  • the damaged tissue can be accurately positioned, and the damaged tissue area and the normal tissue area can be accurately divided.
  • the miniature tweezers built into the in vivo micro-robot device are remotely controlled, and the puncture is retractable. Needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize cutting, suturing, puncturing, cauterization, laser cutting, targeted therapy.
  • the region realizes the smallest side effects of the drug administration and the optimized drug administration effect.
  • Retractable and precise drug delivery device used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
  • Organs double accurate positioning of damaged tissues, double accurate identification methods.
  • the in-vivo vision device and the in-vitro imaging device can accurately identify human organs, damaged tissues, and divide the normal area and the damaged area with high precision.
  • the method of robot double image matching, positioning, and accurately dividing the diseased position of damaged tissue and normal tissue including the following steps:
  • the micro-robot publishes the position area and coordinate boundary of the organ in the image under the in vivo microscope, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates.
  • the in vitro imaging system module publishes the position area of the organ and its coordinate boundary of the in vitro imaging image, and the robot main system and the intelligent identification module subscribe to the published image and position coordinates.
  • the intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
  • Optimal methods are used to regulate drugs and treatment methods. The specific steps of control are as follows:
  • Drug regulation includes: drug selection, drug dosage, and drug cycle.
  • Modulated treatment methods include: internal surgery, precision medicine with common drugs, targeted therapy, radiation therapy, radioactive seed implantation, and ablation therapy. Set the comprehensive indicators of multiple treatments as multi-objectives, and optimize the control treatment plan.
  • the optimization methods include: genetic calculation method and its improvement method, tabu search calculation method and its improvement method, simulated annealing calculation method and its improvement method, ant colony calculation method and its improvement method, particle beam optimization calculation method One or more of methods for improving and improving methods thereof, neural network computing methods and methods for improving them, and methods for evolution and methods for improving them.
  • Monitored indicators of the internal immune environment of the body, and indicators of the tumor treatment microenvironment are constant.
  • the optimal tumor treatment microenvironment the absolute value of the difference between the monitoring index and the standard index * the sum of the weights.
  • the main treatment methods in vivo surgery, precision medicine treatment, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy, etc.
  • main drug main drug (main drug m m ⁇ 1, 2, ....M ⁇ )
  • Monitoring indicators monitor e e ⁇ 1, 2, ....E ⁇ , monitoring real-time indicators monitor e-realtime , monitoring indicators standard monitor e-std side effects monitoring indicators monitor sub-b b ⁇ 1, 2, ... .B ⁇ .
  • the number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
  • Constraints include:
  • Multi-target includes:
  • the body's internal immune environment is optimal,
  • the drug is optimally regulated, the amount of the drug, the precise positioning of the carcinogenic site, the specific tumor cell, and the delivery. Drugs to achieve optimal regulation of treatment.
  • a high-precision positioning, remote-controlled non-invasive in-vivo surgical method and a remote and autonomous drug administration method comprises the following steps:
  • the main control system publishes disease images and location information of damaged tissues.
  • the robot driving module, the radio frequency receiver or the electromagnetic guidance autonomous positioning mobile module subscribes to the location message.
  • the radio frequency receiver or the electromagnetic guided magnetic guided autonomous positioning and moving module guides the internal magnetic device to drive the micro robot to swim and move to the position of the damaged tissue.
  • the double-precision positioning and double-precision identification method of damaged tissue High-precision division of normal areas and damaged areas.
  • the action planning instruction message is released, the robot checks the surgical device, and the robot treatment device subscribes to the instruction message.
  • the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
  • step S6 the robot inspects the surgical device module, images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage.
  • the doctor remotely controls the micro forceps, micro forceps, puncture and retractable needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, laser device and other surgical devices built into the micro robot in the body, inspecting damaged tissue and performing surgical operations , to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
  • step S6 the robot treatment and drug administration action planning module images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage.
  • the main control system publishes the returned drug delivery route and the position coordinates of each seeding point.
  • the doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.
  • the invention can solve the problem of remote control of the micro-robot through the micro-robot device, magnetically guided movement, intelligent identification of organs, diseases, and damaged tissues by means of dual visual recognition devices, locating their positions, and moving to their positions, using micro-surgical devices, laser emitting devices , radio frequency devices, ablation, treatment of diseases in vivo.
  • a high-precision positioning, remote control non-invasive in-vivo surgical method and a remote and autonomous drug delivery method solve and effectively utilize the optimal drug delivery device, and achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
  • the doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
  • the present invention can monitor and regulate in vivo state in real time by optimizing the regulation system, so as to realize the optimal treatment in vivo.
  • Fig. 1 is the schematic diagram of the micro-robot device module in the specification of the present application, and Fig. 1 is marked:
  • 101-main control system 101-main control system; 102-multi-sensing module; 103-in vivo camera vision module, lighting module; 104-guidance module;
  • 109-precise drug delivery module 110-in vitro imaging system; 111-remote control module;
  • 201-vision device 202-camera; 203-in vivo guidance device; 204-miniature surgical device;
  • 205-therapeutic device 206-multi-sensing; 207-drive device; 208-telescopic support, fixing device;
  • 209-main control system 210-in vitro imaging system; 211-in vitro guidance device; 212 precise drug delivery device;
  • the purpose of the present invention is to design a micro-robot device capable of remote control in vivo that can replace human work, realize real-time monitoring in vivo, non-invasive treatment, intelligent identification of organs, diseases, and damaged tissue images by dual-vision recognition device, and effectively improve the accuracy of surgery.
  • the doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
  • the dual-visual recognition device is used to intelligently identify organs, diseases, and damaged tissues.
  • the micro-robot locates the damaged tissue in the body, and double-accurately divides the damaged tissue area and the normal tissue area, positioning, and moving.
  • Remote control by administrators, non-invasive in-vivo surgery, high-precision positioning, remote control of in-vivo micro-robots Built-in micro forceps, micro forceps, puncture retractable needles, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, Laser devices and other surgical devices check and perform surgical operations to achieve cutting and suturing, puncture, cautery, laser cutting, and targeted therapy.
  • Remote and autonomous drug delivery using the optimal drug delivery device to achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
  • a micro-robot device includes:
  • the in vivo micro-robot device includes: a visual recognition module 103, a multi-sensing module 102, a lighting device 103, an in-vivo walking driving device 106, a puncture device, a retractable puncture needle, a pressure device, a surgical inspection and processing device, a treatment device 108, a bracket, a soft bracket , the fixing device 107 , the precise dosing device 111 .
  • the in-vitro imaging 110 a guiding device, is used for in-vitro imaging.
  • the in-vitro imaging system guides the in-vivo micro-robot to position and move autonomously, assists in collecting in-vivo images, assists in identifying in-vivo damaged tissues and tumors, and guides the in-vivo micro-robots to locate in-vivo damaged tissues and tumors.
  • the miniature camera and the visual recognition module 102 in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
  • the illuminating device 103 is used for in-vivo illumination, imaging inspection.
  • the multi-sensing module 102 includes: one or more kinds of sensors such as micro-biological sensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
  • the driving device 106 is used to drive the micro robot to move in vivo.
  • Ultrasound microelectrode array miniature ultrasound probe device, used for acquisition of ultrasound images.
  • surgical treatment device 107 including: micro forceps, micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, one or more of laser devices, with For examination, puncture, surgical operation.
  • Therapeutic device 108 is used to damage tissue into which the tumor drug is placed prior to implantation.
  • the soft stent, the fixing device 105 is used for walking in the body, fixing damaged tissues, and fixing the tumor position during surgical treatment.
  • the precise drug delivery device 111 is used to locate the damaged tissue and the position of the tumor, calculate the size of the damaged tissue, the tumor, and the degree of damage, accurately determine the drug, and administer the drug.
  • the external imaging device 210 and the characteristic positions of human organs, medical images and microscopes, and the method for identifying internal organs under the endoscope 201 include the following steps:
  • the eigenvalues of the human internal organ images corresponding to the external eigenvalues of the organs, the improved deep neural network method and the weight optimizer, through image training, can identify the human organ images under in vitro imaging and in vivo microscopes.
  • the micro-robot publishes the location area and its coordinates of the organs in the images under the in vivo microscope, and uses the coordinate transformation method to establish the coordinate reference transformation of the dual images under the main control system of the robot, so as to realize the matching of the organs and their coordinate positions under the dual images of each organ.
  • Input under the in vivo microscope under the in vitro imaging system to image damaged tissue inflammation, tumor, cyst and other disease models.
  • the disease under the dual system image is identified, and the disease location area, size and return position coordinates are marked and drawn under the dual image.
  • the intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
  • the master control system publishes disease images, information on the location of damaged tissue.
  • the robot driving module 207, radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to subscribe to the location message.
  • the radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to guide the internal magnetic device 203 to drive the micro-robot to swim and move to the position of the damaged tissue.
  • the in vivo vision device 201 and the disease images of the in vitro imaging device 210 issued by the main control system the double accurate positioning of organs and damaged tissues, and the double accurate identification method. High-precision division of normal areas and damaged areas. Determine the scope of surgery to delineate the damaged area, the scope of the drug delivery location and its coordinates.
  • the action planning command message is issued, the robot checks the surgical device, and the robot treatment device subscribes to the command message.
  • the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
  • the robot inspects the surgical device module, imaging in the camera body, and in vitro imaging 210 to guide the device to accurately locate the damaged tissue, and accurately divide the damaged tissue area from the normal tissue area, according to the degree of damage.
  • the doctor remotely controls the built-in micro forceps, micro forceps, puncture and retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, laser devices and other surgical devices 204, damaged tissue inspection and operation. Operation to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
  • Determining drugs and their quantification methods, monitoring the indicators of the body's internal immune environment, and the tumor treatment microenvironment are constant.
  • the main treatment drugs, the dosage of common drugs, and the cycle are variables. Establish the mathematical model of the internal immune environment of the body, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and calculate the optimal internal immune environment of the body.
  • the model variables are as follows:
  • main drug main drug (main drug m m ⁇ 1, 2, ....M ⁇ )
  • Monitoring indicators monitor e e ⁇ 1, 2, ....E ⁇ , monitoring real-time indicators monitor e-realtime , monitoring indicator standards monitor e-std
  • the number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
  • Constraints include:
  • Multi-target includes:
  • the body's internal immune environment is optimal,
  • the optimal regulation of drugs and doses Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of treatment methods and drug methods, the optimal regulation of drugs and doses, accurate positioning of carcinogenic sites, specific tumor cells, drug delivery, To achieve optimal regulation of treatment. Output the medication and dosage in different time periods.
  • plan the amount of radiopharmaceutical (chemotherapy) spraying plan the radiopharmaceutical seeding path, return the drug delivery path and the position coordinates of each seeding point
  • the main control system publishes the returned drug delivery path and the position of each seeding point.
  • the doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Robotics (AREA)
  • Endoscopes (AREA)
  • Electrotherapy Devices (AREA)
  • Manipulator (AREA)
  • Radiation-Therapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

A miniature in-vivo robot device, and an optimal control system and method, which use an artificial intelligence robot technique, and relate to the technical field of miniature robots, and the technical field of intelligent analysis and recognition, radio frequency electromagnetic positioning, etc. The miniature in-vivo robot device comprises a robot main system (101), a multi-sensing module (102), a camera in-vivo illumination vision module (103), a guiding and positioning module (104), a soft support fixing module (105), an in-vivo walking driving module (106), an in-vivo examination and operation processing module (107), a treatment module (108), an accurate drug delivery module (109), an in-vitro imaging module (110) and a distal end control module (111). The device is fed into a human body by means of natural human body cavities such as the oral cavity, the nasal cavity, the auditory meatus, the navel, the vagina and the anus in a radio frequency, electromagnetic and magnetic guiding manner, such that the risk of an in-vitro operation is reduced, thereby essentially achieving non-invasive in-vivo examinations and operations. The in-vivo vision module (103) and the in-vitro imaging module (110) realize double-precision recognition of human organs and damaged tissues, high-precision recognition, high-precision positioning and precise drug delivery of a normal area and a damaged area, realize optimal regulation and control of in-vivo illness conditions, and effectively solve the problems of slow discovery, difficult treatment, poor effect and inaccurate drug delivery. The operation accuracy requirement is high, the risk of an in-vitro operation is reduced, a basic non-invasive effect, real-time monitoring and optimal control are achieved, and major diseases are effectively prevented.

Description

一种体内微型机器人装置,最优化治疗调控系统及方法An in vivo micro-robot device, optimizing the treatment regulation system and method 技术领域:Technical field:
本发明属于人工智能机器人健康医疗设备技术领域,涉及微型机器人技术,人工智能图像智能识别,远程控制,最优化相关理论及技术领域。The invention belongs to the technical field of artificial intelligence robot health medical equipment, and relates to micro-robot technology, artificial intelligence image intelligent recognition, remote control, and optimization related theories and technical fields.
背景技术:Background technique:
目前应用于医疗领域,在器官检查,手术过程由于各种人为因素,器官的疾病识别不准确。体外图像下的诊断不够准确,器官破损位置,破损范围,破损程度不能高精准的诊断及度量。Currently used in the medical field, in organ inspection and surgery, due to various human factors, the disease identification of organs is not accurate. The diagnosis under in vitro images is not accurate enough, and the location of organ damage, the extent of damage, and the degree of damage cannot be diagnosed and measured with high accuracy.
器官,组织破损等体内各项医疗数据指标严重失衡,实时监测体内的数据较为困难,特别是严重疾病,肿瘤等疾病,依靠体制检查等化验,体外超声检查等医疗数据不够准确,不能全面完整的判断病体病情。手术的精准度要求高,无法实时监测血管内的各项数据,血管狭窄,斑块,栓塞等发现慢,治疗难,效果差,治疗栓塞投药不精准,维持畅通良好的血液循环成为重要的课题。Various medical data indicators in the body such as organ and tissue damage are seriously out of balance, and it is difficult to monitor the data in the body in real time, especially for serious diseases, tumors and other diseases. Determine the condition of the patient. The accuracy of the operation is high, and it is impossible to monitor various data in the blood vessel in real time. The discovery of blood vessel stenosis, plaque, embolism, etc. is slow, the treatment is difficult, and the effect is poor. .
可通过口腔,鼻腔,耳道,肚脐,阴道,肛门等人体自然腔道,射频,电磁,磁引导送入体内,减少体外手术的风险,实现基本无创伤,高效地实现了体内实时监测,最优化控制体内病情。It can be delivered into the body through the oral cavity, nasal cavity, ear canal, navel, vagina, anus and other natural human orifices, radio frequency, electromagnetic, magnetic guidance, reducing the risk of external surgery, basically non-invasive, efficient real-time monitoring in vivo, the most Optimal control of the disease in the body.
体内视觉装置,体外成像装置实现高精准采集体内图像,智能识别双图像,辅助识别体内破损组织,肿瘤以及定位其位置。双精准识别人体器官,破损组织,划分正常区域及破损区域的高精准识别。The in-vivo vision device and the in-vitro imaging device realize high-precision acquisition of in-vivo images, intelligently identify dual images, and assist in identifying damaged tissues, tumors and locating their positions in the body. Double-accurate identification of human organs, damaged tissues, high-precision identification of normal areas and damaged areas.
多传感模块,用于体内体环境的实时监测。Multi-sensing module for real-time monitoring of in vivo body environment.
管理员远端控制,通过摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,采用远端操控体内微型机器人装置内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置实现微型切割缝合,穿刺,烧灼,激光切割,靶向治疗。Remote control by the administrator, through the camera in vivo imaging and the in vitro imaging guidance device to accurately locate the damaged tissue, accurately divide the damaged tissue area and the normal tissue area, and use the remote control of the micro-tweezers built in the in-vivo micro-robot device according to the degree of damage. Micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize micro cutting suture, puncture, cautery, laser cutting, targeted therapy.
利用最优化的药物确定以及其定量方法,放射性药物的最优化投药规划方法,实现综合指标多目标最优,调控药物及其定量,实现体内病情最优化调控。Using the optimal drug determination and its quantification method, and the optimal dosing planning method of radiopharmaceuticals, the multi-objective optimization of comprehensive indicators can be achieved, the drug and its quantification can be controlled, and the optimal regulation of the disease in vivo can be achieved.
利用体内微型机器人辅助识别疾病,实时监测体内病情,掌控以最优化施药方式解决体内的疾病,解决体内无创微型手术,激光,消融,靶向治疗,精准投药,有效防止体内重大疾病。Use in vivo micro-robots to assist in identifying diseases, monitor the conditions in the body in real time, and control the optimal drug delivery method to solve the diseases in the body, solve non-invasive micro-surgery, laser, ablation, targeted therapy, and precise drug administration in the body, and effectively prevent major diseases in the body.
发明内容:Invention content:
本发明的目的就在于克服上述现有技术的缺点和不足,提供一种用于体内微型机器人装置,可无创通过磁引导送入体内,减少体外手术的风险。实现基本无创伤手术。双成像装置智能识别疾病,减少人为的诊断治疗失误。传感器实时采集数据,最优化投药,实时监控体内数据,实时跟踪体内治疗的效果,动态调控最优化调整体内药物,药量,精准投药,高效解决肿瘤,组织损伤等问题。The purpose of the present invention is to overcome the above-mentioned shortcomings and deficiencies of the prior art, and to provide a micro-robot device for use in the body, which can be non-invasively delivered into the body through magnetic guidance, thereby reducing the risk of extracorporeal surgery. To achieve basically non-invasive surgery. Dual imaging devices intelligently identify diseases and reduce human errors in diagnosis and treatment. Sensors collect data in real time, optimize drug delivery, monitor in vivo data in real time, track the effect of in vivo treatment in real time, dynamically adjust and optimize in vivo drugs, drug dosage, precise drug administration, and efficiently solve problems such as tumors and tissue damage.
本发明提供了一种管理员远端控制,通过摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,实施治疗,本发明还提供了一种高精准的器官,破损组织的双精准定位,双精准识别方法。The invention provides a remote control for administrators, which can accurately locate damaged tissue through in-vivo imaging of a camera and an in-vitro imaging guide device, accurately divide the damaged tissue area and the normal tissue area, and implement treatment according to the degree of damage. The invention also provides A high-precision organ, double-accurate positioning of damaged tissue, and double-accurate identification method.
本发明还提供了一种利用最优化的药物确定以及其定量方法,放射性药物的最优化投药规划方法,实现综合指标多目标最优,调控药物及其定量,实现体内病情最优化调控,本发明还提供了一种高精准定位,远端控制的无创体内手术方法以及远端及自主的投药方法。The present invention also provides a method for determining and quantifying a drug using an optimized method, an optimized dosing planning method for radiopharmaceuticals, realizing multi-objective optimization of comprehensive indicators, regulating drugs and their quantification, and realizing optimal regulation of in vivo conditions. Also provided is a high-precision positioning, remote-controlled non-invasive in vivo surgical method and a remote and autonomous drug delivery method.
实现体内无创微型手术,激光,消融,靶向治疗,精准投药,有效治疗体内重大疾病,通过远端控制微型机器人,图像识别,高效率灵活解决临床案例。Realize non-invasive micro-surgery in vivo, laser, ablation, targeted therapy, precise drug delivery, effectively treat major diseases in the body, and solve clinical cases efficiently and flexibly through remote control of micro-robots and image recognition.
本发明的采用的技术方案:The technical scheme adopted in the present invention:
一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,一种体内微型机器人装置包括:An in-vivo micro-robot device, an optimized treatment regulation system and method, is characterized in that, an in-vivo micro-robot device comprises:
主控制系统,所述主控制系统用于控制体内微型机器人装置。体内微型机器人装置包括:视觉识别模块,多传感模块,照明装置,体内行走驱动装置,穿刺装置,可伸缩刺针,压力装置,手术检查处理装置,超声微电极阵列,微型超声探头装置,粒子植入装置,支架,软体支架,固定装置,精准投药装置。A main control system, the main control system is used to control the in vivo micro-robot device. The in vivo micro-robot device includes: visual recognition module, multi-sensing module, lighting device, in-vivo walking drive device, puncture device, retractable puncture needle, pressure device, surgical inspection processing device, ultrasonic microelectrode array, micro ultrasonic probe device, particle implant Insertion device, stent, soft stent, fixation device, precise drug delivery device.
体外成像装置,用于体外成像,包括:超声成像,CT成像,X光成像等多种成像方式中的一种。The in vitro imaging device is used for in vitro imaging, including one of various imaging methods such as ultrasound imaging, CT imaging, and X-ray imaging.
体内的微型摄像头及视觉识别模块,用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置。The miniature camera and visual recognition module in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
光,照明装置,用于体内照明,摄像检查。Light, lighting device, for internal lighting, camera inspection.
多传感模块,包括:微型生物传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息。The multi-sensing module includes: one or more of a variety of sensors such as miniature biosensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
驱动装置,用于驱动机器人在体内无损伤,可控速,有方向的游动。The driving device is used to drive the robot to swim in a non-damaged, speed-controlled and directional manner in the body.
引导,定位,移动装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤。定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置。The guiding, positioning, and moving device is connected with the in vitro imaging device, and the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in-vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in-vivo micro-robot to locate the damaged tissue and tumor in the body. Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices.
软体支架,固定装置,用于体内游动,一时停止,破损组织,肿瘤位置手术处理时固定。Soft stent, fixation device, used for swimming in the body, temporary stop, damaged tissue, and fixation of tumor location during surgical treatment.
可伸缩的体内检查,手术处理装置,包括:微型的镊子,微型钳子,穿刺用刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种。用于体内检查,穿刺,手术操作,消融治疗。Retractable in-vivo inspection and surgical treatment devices, including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device. For internal examination, puncture, surgical operation, ablation treatment.
可伸缩的治疗,精准投药装置,可伸缩的治疗装置,用于破损组织,药物粒子植入,放置装置,用于放射治疗,放射性粒子植入治疗等。可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损 组织,肿瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。Retractable treatment, precise drug delivery device, retractable treatment device for damaged tissue, drug particle implantation, placement device for radiation therapy, radioactive particle implantation therapy, etc. Retractable and precise drug delivery device, used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
通过口腔,鼻腔,耳道,肚脐,阴道,肛门等器官,体内通过电磁,射频,磁等引导装置移动定位,减少体外手术创伤大风险高,实现基本无创伤,体内检查,手术,高效地实现了体内实时监测,最优化控制体内病情。Through the oral cavity, nasal cavity, ear canal, navel, vagina, anus and other organs, the body is moved and positioned by electromagnetic, radio frequency, magnetic and other guiding devices, reducing the high risk of external surgical trauma, and achieving basic non-invasive, internal inspection, surgery, and efficient realization In vivo real-time monitoring, optimal control of in vivo conditions.
双精准的成像方式,采用微型摄像头的体内摄像头及视觉识别模块与体外成像装置协同作业,高精准采集,辅助识别器官,破损组织,肿瘤等图像,准确识别破损组织及正常组织区域。体内摄像头及视觉识别模块用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置。所述的视觉识别模块包括:微型内窥镜,微型显微镜等体内成像装置中的一种与多种以及3D成像系统与体外成像引导装置协同作业,采集并智能识别体内多种疾病图像。Dual-accurate imaging methods, using the in-vivo camera and visual recognition module of the miniature camera to work together with the in-vitro imaging device, high-precision acquisition, assisting in identifying images of organs, damaged tissues, tumors, etc., and accurately identifying damaged tissues and normal tissue areas. The in-vivo camera and visual recognition module are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions. The visual recognition module includes: one or more of in vivo imaging devices such as a micro endoscope and a micro microscope, and a 3D imaging system cooperates with an in vitro imaging guide device to collect and intelligently identify images of various diseases in the body.
驱动装置驱动机器人在体内无损伤,可控速,有方向的游动。利用软体支架,固定装置一时性固定,辅助体内机器人实施手术,破损组织检查等完成体内治疗。利用定位,引导装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤。体内游动,驱动装置,用于驱动微型机器人体内移动,行走,游动。驱动装置包括:电流驱动,电磁驱动及磁驱动中的一种。定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置。软体支架,固定装置,用于体内组织检查,破损组织,肿瘤位置的手术处理时的固定。The driving device drives the robot to swim without damage in the body, with controllable speed and direction. Use soft stents and fixation devices to temporarily fix, assist in-vivo robots to perform surgery, check damaged tissue, etc. to complete in-vivo treatment. Using the positioning and guiding device, connected with the in vitro imaging device, the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in vivo micro-robot to locate the damaged tissue and tumor in the body. In vivo swimming, driving device, used to drive the micro robot to move, walk and swim in the body. The driving device includes one of current driving, electromagnetic driving and magnetic driving. Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices. Soft stent, fixation device, used for in vivo tissue examination, damaged tissue, fixation during surgical treatment of tumor location.
多传感模块实时监测体内环境。多传感包括:微型生物传感,微型医疗传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息,实时监测体内环境。体内体环境包括:体内免疫环境以及肿瘤治疗微环境等治疗,监测期间的体内环境。The multi-sensing module monitors the in vivo environment in real time. Multi-sensing includes: one or more of various sensors such as micro bio-sensing, micro-medical sensing, and comprehensive gene sensing, which are used to collect sensor information in vivo and monitor the in-vivo environment in real time. The in vivo environment includes: the in vivo immune environment and the tumor treatment microenvironment, and the in vivo environment during monitoring.
体内检查,手术处理装置。手术检查处理装置,包括:微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种。用于检查,穿刺,手术操作。通过摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,采用远端操控体内微型机器人装置内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置实现切割,缝合,穿刺,烧灼,激光切割,靶向治疗。In vivo examination, surgical treatment device. Surgical inspection and processing devices, including: one or more of micro forceps, micro forceps, puncture retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, and laser devices. For inspection, puncture, surgical operation. Through in vivo imaging of the camera and in vitro imaging guidance device, the damaged tissue can be accurately positioned, and the damaged tissue area and the normal tissue area can be accurately divided. According to the degree of damage, the miniature tweezers built into the in vivo micro-robot device are remotely controlled, and the puncture is retractable. Needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize cutting, suturing, puncturing, cauterization, laser cutting, targeted therapy.
可伸缩的治疗,精准投药装置,粒子植入装置以及依照破损位置,破损区域尺寸,破损程度的药品定量最优化方法,实现精准投药,精准的靶向治疗,准确划分破损的组织区域与正常组织区域实现投药副作用最小,投药效果最优化。可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损组织,肿 瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。Scalable treatment, precise drug delivery device, particle implantation device, and quantitative optimization method of drugs according to the damaged position, the size of the damaged area, and the degree of damage, to achieve precise drug delivery, precise targeted therapy, and accurately divide the damaged tissue area from normal tissue. The region realizes the smallest side effects of the drug administration and the optimized drug administration effect. Retractable and precise drug delivery device, used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
器官,破损组织的双精准定位,双精准识别方法。体内视觉装置,体外成像装置双精准识别人体器官,破损组织,划分正常区域及破损区域的高精准识别。Organs, double accurate positioning of damaged tissues, double accurate identification methods. The in-vivo vision device and the in-vitro imaging device can accurately identify human organs, damaged tissues, and divide the normal area and the damaged area with high precision.
体外的成像装置及人体器官特征位置及医疗图像与显微镜,内窥镜下内部脏器识别方法,包括以下步骤:An in vitro imaging device and a characteristic position of human organs, a medical image and a microscope, and a method for recognizing internal organs under an endoscope, comprising the following steps:
S1、建立体外成像图像及体内显微镜下的人体器官的轮廓,形状,纹理,颜色,尺寸等的特征模型。S1. Establish a characteristic model of the contour, shape, texture, color, size, etc. of the human organ under the in vitro imaging image and the in vivo microscope.
S2、建立破损组织炎症,肿瘤,囊肿等多种疾病模型。S2. Establish various disease models such as damaged tissue inflammation, tumor, cyst, etc.
S3、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓,各器官的特征值及其对应的外部特征所对应的人体外部位置区。S3, extracting the in vitro imaging image and the internal contour of the image organ under the in vivo microscope, the characteristic value of each organ and the external position area of the human body corresponding to the corresponding external characteristic.
S4、输入体外成像图像及体内显微镜下的图像的各器官外部特征值所对应的人体内部器官图像的特征值,改进深度神经网络方法及权值优化器,通过图像训练,得到输出值及内部器官分类,器官识别结果。S4. Input the eigenvalues of the human internal organ images corresponding to the external eigenvalues of each organ of the in vitro imaging image and the image under the in vivo microscope, improve the deep neural network method and the weight optimizer, and obtain the output values and internal organs through image training Classification, organ identification results.
S5、输出结果,精准分类,识别体外成像及体内显微镜下的人体器官图像。S5. Output results, accurately classify, and identify human organ images under in vitro imaging and in vivo microscopes.
机器人双图像匹配,定位,精准划分破损组织的疾病位置及正常组织的方法,包括以下步骤:The method of robot double image matching, positioning, and accurately dividing the diseased position of damaged tissue and normal tissue, including the following steps:
S1、微型机器人发布体内显微镜下图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标。S1. The micro-robot publishes the position area and coordinate boundary of the organ in the image under the in vivo microscope, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates.
S2、体外成像系统模块发布体外成像图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标。S2. The in vitro imaging system module publishes the position area of the organ and its coordinate boundary of the in vitro imaging image, and the robot main system and the intelligent identification module subscribe to the published image and position coordinates.
S3、利用坐标转换方法,建立机器人主控制系统下双图像的坐标参照转换,各器官的双图像下的器官及其坐标位置匹配。S3. Using the coordinate transformation method, establish the coordinate reference transformation of the dual images under the robot main control system, and match the organs and their coordinate positions under the dual images of each organ.
S4、建立体内显微镜下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型。S4. Establish a model of various diseases such as inflammation, tumor, cyst, etc. of damaged tissue images under an in vivo microscope.
S5、建立体外成像系统下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型。S5. Establish a model of various diseases such as inflammation, tumor, cyst and the like in image damaged tissue under the in vitro imaging system.
S6、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓及其疾病模型下的特征值及其对应的位置区,位置坐标。S6, extracting the in vitro imaging image and the image under the in vivo microscope, the internal contour of the organ and its characteristic value under the disease model, its corresponding position area, and position coordinates.
S7、利用改进的神经网络方法及权值优化器,识别双系统图像下的疾病,标注并画出双图像下的疾病位置区域,尺寸,返回位置坐标。S7. Use the improved neural network method and weight optimizer to identify the disease under the dual-system image, mark and draw the disease location area and size under the dual-image, and return the location coordinates.
S8、智能识别模块输出疾病种类,疾病器官及其器官下异常病症的位置区域,返回其识别结果至主控制系统。S8. The intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
采用最优化的方法调控药物及治疗方法。调控的具体步骤如下:Optimal methods are used to regulate drugs and treatment methods. The specific steps of control are as follows:
药物调控包括:药物选择,药物的用量,药物的周期。调控治疗方法包括:体内手术,普通药物精准 治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式。设定多种治疗的综合指标为多目标,最优化调控治疗方案。其中,最优化的方法包括:遗传计算方法及其改进方法,禁忌搜索计算方法及其改进方法,模拟退火计算方法及其改进方法,蚁群计算方法及其改进方法,粒子束最优化的计算方法及其改进方法,神经网络计算方法及其改进方法,进化方法及其改进方法,中的一种及多种。通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗。Drug regulation includes: drug selection, drug dosage, and drug cycle. Modulated treatment methods include: internal surgery, precision medicine with common drugs, targeted therapy, radiation therapy, radioactive seed implantation, and ablation therapy. Set the comprehensive indicators of multiple treatments as multi-objectives, and optimize the control treatment plan. Among them, the optimization methods include: genetic calculation method and its improvement method, tabu search calculation method and its improvement method, simulated annealing calculation method and its improvement method, ant colony calculation method and its improvement method, particle beam optimization calculation method One or more of methods for improving and improving methods thereof, neural network computing methods and methods for improving them, and methods for evolution and methods for improving them. Through the combination of static treatment effect prediction and real-time dynamic adjustment of treatment methods and drug methods, optimal regulation of drugs and doses, accurate positioning of carcinogenic sites, specific tumor cells, and drug delivery to achieve optimal regulation and treatment.
S1.监测的身体内部免疫环境的指标,肿瘤治疗微环境的指标为常量。S1. Monitored indicators of the internal immune environment of the body, and indicators of the tumor treatment microenvironment are constant.
身体内部免疫环境最优---监测指标与标准指标差的绝对值*权值的总和。The optimal immune environment in the body---the absolute value of the difference between the monitoring index and the standard index * the sum of the weights.
肿瘤治疗微环境最优-----监测指标与标准指标差的绝对值*权值的总和。The optimal tumor treatment microenvironment—the absolute value of the difference between the monitoring index and the standard index * the sum of the weights.
S2.主要的治疗方法(体内手术,普通药物精准治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式)S2. The main treatment methods (in vivo surgery, precision medicine treatment, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy, etc.)
以及普通药物治疗的药物选择,药物用量,时间周期为变量。As well as drug selection, drug dosage, and time period for common drug therapy are variables.
S3.分别建立身体内部免疫环境的数学模型,肿瘤治疗微环境最优数学模型,肿瘤治疗副作用数学模型,药物抵达数学模型如下:S3. Establish the mathematical model of the body's internal immune environment, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and the mathematical model of drug arrival as follows:
变量:variable:
药品的分类:主要治疗药物(main drug mm∈{1,2,....M}) Classification of drugs: main drug (main drug m m∈{1, 2, ....M})
普通调解药物(drug nn∈{1,2,....N}) Common Mediation Drug (drug n n∈{1,2,....N})
主要疗效施药
Figure PCTCN2022000044-appb-000001
主要疗效未施药
Figure PCTCN2022000044-appb-000002
main therapeutic effect
Figure PCTCN2022000044-appb-000001
Primary efficacy not administered
Figure PCTCN2022000044-appb-000002
普通药物施药
Figure PCTCN2022000044-appb-000003
普通药物未施药
Figure PCTCN2022000044-appb-000004
General drug administration
Figure PCTCN2022000044-appb-000003
Common medicines not administered
Figure PCTCN2022000044-appb-000004
主药品的施药数量
Figure PCTCN2022000044-appb-000005
The amount of the main drug applied
Figure PCTCN2022000044-appb-000005
普通药品施药数量
Figure PCTCN2022000044-appb-000006
Quantity of common medicines applied
Figure PCTCN2022000044-appb-000006
治疗周期(t tt∈{1,2,....T}). treatment period (t t t∈{1, 2, ....T}).
治疗周期难愈参数
Figure PCTCN2022000044-appb-000007
Treatment cycle refractory parameters
Figure PCTCN2022000044-appb-000007
疾病(D dd∈{1,2,....D}). disease(D d d∈{1, 2, ....D}).
破损点数量
Figure PCTCN2022000044-appb-000008
Number of damage points
Figure PCTCN2022000044-appb-000008
破损组织区域尺寸
Figure PCTCN2022000044-appb-000009
Damaged tissue area size
Figure PCTCN2022000044-appb-000009
疾病程度/破损程度
Figure PCTCN2022000044-appb-000010
Degree of disease/damage
Figure PCTCN2022000044-appb-000010
治疗方法参数Treatment method parameters
包括主要的治疗方法(硬性治疗指标
Figure PCTCN2022000044-appb-000011
)及普通药物治疗方法
Figure PCTCN2022000044-appb-000012
Including the main treatment method (hard treatment index
Figure PCTCN2022000044-appb-000011
) and common drug treatments
Figure PCTCN2022000044-appb-000012
疾病治疗的基本的效果
Figure PCTCN2022000044-appb-000013
Basic effects of disease treatment
Figure PCTCN2022000044-appb-000013
监测指标monitor ee∈{1,2,....E},监测实时指标monitor e-realtime,监测指标标准monitor e-std副作用监测指标monitor sub-bb∈{1,2,....B}. Monitoring indicators monitor e e∈{1, 2, ....E}, monitoring real-time indicators monitor e-realtime , monitoring indicators standard monitor e-std side effects monitoring indicators monitor sub-b b∈{1, 2, ... .B}.
drug n免疫效力参数
Figure PCTCN2022000044-appb-000014
drug n immune potency parameters
Figure PCTCN2022000044-appb-000014
main drug m微环境效力参数
Figure PCTCN2022000044-appb-000015
Main drug m microenvironment potency parameters
Figure PCTCN2022000044-appb-000015
main drug m肿瘤治疗副作用负面指标效力
Figure PCTCN2022000044-appb-000016
main drug m tumor treatment side effects negative indicators efficacy
Figure PCTCN2022000044-appb-000016
●身体内部免疫环境最优:●The optimal immune environment in the body:
Figure PCTCN2022000044-appb-000017
Figure PCTCN2022000044-appb-000017
●肿瘤治疗微环境最优:Optimal tumor treatment microenvironment:
Figure PCTCN2022000044-appb-000018
Figure PCTCN2022000044-appb-000018
●肿瘤治疗副作用最小:●Minimum side effects of tumor treatment:
Figure PCTCN2022000044-appb-000019
Figure PCTCN2022000044-appb-000019
●药物抵达最优:●The drug arrives optimally:
Figure PCTCN2022000044-appb-000020
Figure PCTCN2022000044-appb-000020
规划的施药数量多为放射药物,靶向药物,化疗药物等的药物。The number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
●治疗周期最短:●Shortest treatment cycle:
Figure PCTCN2022000044-appb-000021
Figure PCTCN2022000044-appb-000021
S4.制约条件包括:S4. Constraints include:
1)时间周期内的药物最大用量上限范围内1) Within the upper limit of the maximum dosage of the drug within the time period
2)药物最长使用周期范围内2) Within the longest period of use of the drug
3)用药周期标准值范围内3) Within the range of the standard value of the medication cycle
4)破损组织的区域范围内4) Within the area of damaged tissue
5)治疗期内的最大副作用的承受能力范围内5) Within the tolerance range of the maximum side effects during the treatment period
6)满足疾病的基本用药治疗疗效。6) To meet the basic drug treatment efficacy of the disease.
7)满足药物的基本用量。7) Meet the basic dosage of the drug.
S5.多目标包括:S5. Multi-target includes:
身体内部免疫环境最优,The body's internal immune environment is optimal,
肿瘤治疗微环境最优Optimal tumor treatment microenvironment
治疗副作用最小Treatment with minimal side effects
药物抵达最优Optimal drug arrival
治疗周期最短The shortest treatment period
MIN(F)MIN(F)
Figure PCTCN2022000044-appb-000022
Figure PCTCN2022000044-appb-000022
S6.通过最优化方法中的一种及多种,通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗。S6. Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of the treatment method and drug method, the drug is optimally regulated, the amount of the drug, the precise positioning of the carcinogenic site, the specific tumor cell, and the delivery. Drugs to achieve optimal regulation of treatment.
S7.输出不同时间周期内的用药及用药量。S7. Output the medication and the amount of medication in different time periods.
一种高精准定位,远端控制的无创体内手术方法以及远端及自主的投药方法,所述方法包括以下步骤:A high-precision positioning, remote-controlled non-invasive in-vivo surgical method and a remote and autonomous drug administration method, the method comprises the following steps:
S1、主控制系统发布疾病图像,破损组织的位置消息。S1. The main control system publishes disease images and location information of damaged tissues.
S2、机器人驱动模块,射频接收器或电磁引导自主定位移动模块订阅位置消息。S2. The robot driving module, the radio frequency receiver or the electromagnetic guidance autonomous positioning mobile module subscribes to the location message.
S3、射频接收器或电磁引导磁引导自主定位移动模块引导体内磁装置驱动微型机器人游动,移动至破 损组织的位置。S3. The radio frequency receiver or the electromagnetic guided magnetic guided autonomous positioning and moving module guides the internal magnetic device to drive the micro robot to swim and move to the position of the damaged tissue.
S4、依据主控制系统发布的体内视觉装置,体外成像装置的疾病图像,依据权利要求7所述的器官,破损组织的双精准定位,双精准识别方法。高精准划分正常区域及破损区域。S4. According to the in-vivo vision device and the disease image of the in-vitro imaging device released by the main control system, according to the organ according to claim 7, the double-precision positioning and double-precision identification method of damaged tissue. High-precision division of normal areas and damaged areas.
S5、确定划定破损区域的手术范围,投药位置范围及其坐标。S5. Determine the scope of surgery to delineate the damaged area, the scope of the drug administration position and its coordinates.
S6、依据主控制系统发布动作规划指令消息,机器人检查手术装置,机器人治疗装置订阅指令消息。S6. According to the main control system, the action planning instruction message is released, the robot checks the surgical device, and the robot treatment device subscribes to the instruction message.
进一步,所述动作规划模块,包括机器人检查手术动作规划,机器人治疗投药动作规划。Further, the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
S7、步骤S6中,所述的机器人检查手术装置模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度。医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置,破损组织检查及执行手术操作,实现切割,缝合,穿刺,烧灼,电刀,激光切割,靶向治疗。S7. In step S6, the robot inspects the surgical device module, images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage. The doctor remotely controls the micro forceps, micro forceps, puncture and retractable needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, laser device and other surgical devices built into the micro robot in the body, inspecting damaged tissue and performing surgical operations , to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
S8、步骤S6中,所述的机器人治疗投药动作规划模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度。S8. In step S6, the robot treatment and drug administration action planning module images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage.
S9、利用权利要求9所述的治疗综合指标多目标最优化调控方法,规划放射药物(化疗药物)施药的数量,规划放射药物播种路径,返回投药路径以及各播种点位置坐标。S9. Using the multi-objective optimal control method for comprehensive treatment indicators according to claim 9, plan the amount of radiopharmaceutical (chemotherapy) spraying, plan the radiopharmaceutical seeding path, return the drug delivery path and the position coordinates of each seeding point.
S10、主控制系统发布按照返回的投药路径以及各播种点位置坐标,医生远端操控以及自主控制投药装置,移动投药装置至投药的各播种点实施投药。S10. The main control system publishes the returned drug delivery route and the position coordinates of each seeding point. The doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.
S11、返回任务完成。S11 , the return task is completed.
综上,本发明的有益效果是:To sum up, the beneficial effects of the present invention are:
本发明能够通过微型机器人装置,解决远端控制微型机器人,磁引导移动,利用双视觉识别装置智能识别器官,疾病,破损组织,定位其位置,移动到其位置,利用微型手术装置,激光发射装置,射频装置,消融,治疗体内疾病。The invention can solve the problem of remote control of the micro-robot through the micro-robot device, magnetically guided movement, intelligent identification of organs, diseases, and damaged tissues by means of dual visual recognition devices, locating their positions, and moving to their positions, using micro-surgical devices, laser emitting devices , radio frequency devices, ablation, treatment of diseases in vivo.
一种高精准定位,远端控制无创体内手术方法以及远端及自主的投药方法,解决并有效利用最优化投药装置,通过计算完成药品,药品用量,药品周期实现治疗最优化。A high-precision positioning, remote control non-invasive in-vivo surgical method and a remote and autonomous drug delivery method solve and effectively utilize the optimal drug delivery device, and achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置检查及执行手术操作,实现切割缝合,穿刺,烧灼,激光切割,靶向治疗。The doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
改善了医生,护士等人员手术失误多等问题,大幅度提高工作效率。本发明能够通过最优化调控系统,实时监测,调控体内状态,实现体内治疗最优。It has improved the problems of doctors, nurses and other personnel with many surgical errors, and greatly improved work efficiency. The present invention can monitor and regulate in vivo state in real time by optimizing the regulation system, so as to realize the optimal treatment in vivo.
附图说明:Description of drawings:
图1是本申请说明书中微型机器人装置模块示意图,附图1标记:Fig. 1 is the schematic diagram of the micro-robot device module in the specification of the present application, and Fig. 1 is marked:
101-主控制系统;       102-多传感模块;       103-体内摄像头视觉模块,照明模块; 104-引导模块;101-main control system; 102-multi-sensing module; 103-in vivo camera vision module, lighting module; 104-guidance module;
105-软体支架固定装置; 106-体内行走驱动支架; 107-体内检查手术模块; 108-治疗模块;105-soft bracket fixing device; 106-in vivo walking drive bracket; 107-in vivo inspection surgery module; 108-treatment module;
109-精准投药模块;     110-体外成像系统;     111-远端控制模块;109-precise drug delivery module; 110-in vitro imaging system; 111-remote control module;
图2是本申请说明书中微型机器人装置组成结构示意图,附图2标记:2 is a schematic diagram of the composition of the micro-robot device in the description of the application, and the accompanying drawing 2 is marked:
201-视觉装置;       202-摄像头;          203-体内引导装置;    204-微型手术装置;201-vision device; 202-camera; 203-in vivo guidance device; 204-miniature surgical device;
205-治疗装置;       206-多传感;          207-驱动装置;        208-伸缩支架,固定装置;205-therapeutic device; 206-multi-sensing; 207-drive device; 208-telescopic support, fixing device;
209-主控制系统;     210-体外成像系统;    211-体外引导装置;    212精准投药装置;209-main control system; 210-in vitro imaging system; 211-in vitro guidance device; 212 precise drug delivery device;
具体实施方式Detailed ways
本发明的目的是设计取代人类工作的可远端控制体内微型机器人装置,实现体内实时监测,无创伤治疗,双视觉识别装置智能识别器官,疾病,破损组织图像,有效地提高手术的精准度。The purpose of the present invention is to design a micro-robot device capable of remote control in vivo that can replace human work, realize real-time monitoring in vivo, non-invasive treatment, intelligent identification of organs, diseases, and damaged tissue images by dual-vision recognition device, and effectively improve the accuracy of surgery.
双精准图像高精准定位,远端控制无创体内手术。Dual-precision image high-precision positioning, remote control of non-invasive internal surgery.
有效利用最优化投药装置,通过计算完成药品,药品用量,药品周期实现治疗最优化。Effective use of the optimal drug delivery device, through the calculation of the drug, drug dosage, drug cycle to achieve the optimization of treatment.
医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置检查及执行手术操作,实现切割缝合,穿刺,烧灼,激光切割,靶向治疗。The doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
有效解决了人为诊断,治疗,手术的失误,实现远端控制手术,自主投药。为了更好的理解上述技术方案,下面结合实施例及附图,对本发明作进一步地的详细说明,但本发明的实施方式不限于此。It effectively solves the errors of human diagnosis, treatment and operation, and realizes remote control operation and self-administration. In order to better understand the above technical solutions, the present invention will be further described in detail below with reference to the embodiments and the accompanying drawings, but the embodiments of the present invention are not limited thereto.
本申请实施中的技术方案为解决上述技术问题的总体思路如下:The technical solution in the implementation of the present application is the general idea of solving the above-mentioned technical problems as follows:
通过微型机器人的主控制系统,利用双视觉识别装置智能识别器官,疾病,坏损组织,微型机器人定位体内的坏损组织,双精准划分坏损组织区域及正常的组织区域,定位,移动。Through the main control system of the micro-robot, the dual-visual recognition device is used to intelligently identify organs, diseases, and damaged tissues. The micro-robot locates the damaged tissue in the body, and double-accurately divides the damaged tissue area and the normal tissue area, positioning, and moving.
管理员远端控制,无创体内手术,高精准定位,远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置检查及执行手术操作,实现切割缝合,穿刺,烧灼,激光切割,靶向治疗。Remote control by administrators, non-invasive in-vivo surgery, high-precision positioning, remote control of in-vivo micro-robots Built-in micro forceps, micro forceps, puncture retractable needles, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, Laser devices and other surgical devices check and perform surgical operations to achieve cutting and suturing, puncture, cautery, laser cutting, and targeted therapy.
远端及自主的投药,利用最优化投药装置,通过计算药品,药品用量,药品周期实现治疗最优化。Remote and autonomous drug delivery, using the optimal drug delivery device to achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
实施例1:Example 1:
如图1,如图2所示,一种微型机器人装置包括:As shown in Figure 1 and Figure 2, a micro-robot device includes:
主控制系统101,所述主控制系统101用于控制体内微型机器人装置。体内微型机器人装置包括:视觉识别模块103,多传感模块102,照明装置103,体内行走驱动装置106,穿刺装置,可伸缩刺针,压力装置,手术检查处理装置,治疗装置108,支架,软体支架,固定装置107,精准投药装置111。A main control system 101, the main control system 101 is used to control the in vivo micro-robot device. The in vivo micro-robot device includes: a visual recognition module 103, a multi-sensing module 102, a lighting device 103, an in-vivo walking driving device 106, a puncture device, a retractable puncture needle, a pressure device, a surgical inspection and processing device, a treatment device 108, a bracket, a soft bracket , the fixing device 107 , the precise dosing device 111 .
体外成像110,引导装置,用于体外成像,通过体外成像系统引导体内微型机器人自主定位移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤。The in-vitro imaging 110, a guiding device, is used for in-vitro imaging. The in-vitro imaging system guides the in-vivo micro-robot to position and move autonomously, assists in collecting in-vivo images, assists in identifying in-vivo damaged tissues and tumors, and guides the in-vivo micro-robots to locate in-vivo damaged tissues and tumors.
体内的微型摄像头及视觉识别模块102,用于采集体内图像,辅助识别体内破损组织,肿瘤以及定位其位置。The miniature camera and the visual recognition module 102 in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
光,照明装置103,用于体内照明,摄像检查。Light, the illuminating device 103, is used for in-vivo illumination, imaging inspection.
多传感模块102,包括:微型生物传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息。The multi-sensing module 102 includes: one or more kinds of sensors such as micro-biological sensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
体内行走,驱动装置106,用于驱动微型机器人体内移动。In vivo walking, the driving device 106 is used to drive the micro robot to move in vivo.
超声微电极阵列,微型超声探头装置,用于超声图像的采集。Ultrasound microelectrode array, miniature ultrasound probe device, used for acquisition of ultrasound images.
体内检查,手术处理装置107,包括:微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种,用于检查,穿刺,手术操作。In-vivo inspection, surgical treatment device 107, including: micro forceps, micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, one or more of laser devices, with For examination, puncture, surgical operation.
治疗装置108,用于破损组织,肿瘤药物植入前放置其中。 Therapeutic device 108 is used to damage tissue into which the tumor drug is placed prior to implantation.
软体支架,固定装置105,用于体内行走,破损组织,肿瘤位置的手术处理时的固定。The soft stent, the fixing device 105, is used for walking in the body, fixing damaged tissues, and fixing the tumor position during surgical treatment.
精准投药装置111,用于定位破损组织,肿瘤的位置,计算破损组织,肿瘤的尺寸,破损程度,精准定药,投药。The precise drug delivery device 111 is used to locate the damaged tissue and the position of the tumor, calculate the size of the damaged tissue, the tumor, and the degree of damage, accurately determine the drug, and administer the drug.
实施例2:Example 2:
如图2所示,血管内图片实时采集,血管内图像数据,传感器数据疾病的智能识别实施如下:As shown in Figure 2, the real-time collection of intravascular pictures, intravascular image data, and sensor data intelligent identification of diseases is implemented as follows:
体外的成像装置210及人体器官特征位置及医疗图像与显微镜,内窥镜201下内部脏器识别方法,包括以下步骤:The external imaging device 210 and the characteristic positions of human organs, medical images and microscopes, and the method for identifying internal organs under the endoscope 201 include the following steps:
输入体外成像图像及体内显微镜下的人体器官的轮廓,形状,纹理,颜色,尺寸等的特征,输入破损组织炎症,肿瘤,囊肿等多种疾病模型,输入体外成像图像及体内显微镜下图像的各器官外部特征值所对应的人体内部器官图像的特征值,改进深度神经网络方法及权值优化器,通过图像训练,得识别体外成像及体内显微镜下的人体器官图像。Input the contour, shape, texture, color, size and other characteristics of human organs under in vitro imaging images and in vivo microscopes, input damaged tissue inflammation, tumors, cysts and other disease models, input in vitro imaging images and in vivo microscope images. The eigenvalues of the human internal organ images corresponding to the external eigenvalues of the organs, the improved deep neural network method and the weight optimizer, through image training, can identify the human organ images under in vitro imaging and in vivo microscopes.
微型机器人发布体内显微镜下图像的器官的位置区域及其坐标,利用坐标转换方法,建立机器人主控制系统下双图像的坐标参照转换,实现各器官的双图像下的器官及其坐标位置匹配。The micro-robot publishes the location area and its coordinates of the organs in the images under the in vivo microscope, and uses the coordinate transformation method to establish the coordinate reference transformation of the dual images under the main control system of the robot, so as to realize the matching of the organs and their coordinate positions under the dual images of each organ.
输入体内显微镜下,体外成像系统下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型。利用改进的神经网络方法及权值优化器,识别双系统图像下的疾病,标注并画出双图像下的疾病位置区域,尺寸,返回位置坐标。智能识别模块输出疾病种类,疾病器官及其器官下异常病症的位置区域,返回其识别结果至主控制系统。Input under the in vivo microscope, under the in vitro imaging system to image damaged tissue inflammation, tumor, cyst and other disease models. Using the improved neural network method and weight optimizer, the disease under the dual system image is identified, and the disease location area, size and return position coordinates are marked and drawn under the dual image. The intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
实施例3:Example 3:
如图2所示,图片实时采集,高精准定位,远端控制的无创体内手术实施方法如下:As shown in Figure 2, the real-time image acquisition, high-precision positioning, and remote-controlled non-invasive in vivo surgery implementation methods are as follows:
主控制系统发布疾病图像,破损组织的位置消息。机器人驱动模块207,射频,电磁203引导自主定位移动模块订阅位置消息。射频,电磁203引导自主定位移动模块引导体内磁装置203驱动微型机器人游动,移动至破损组织的位置。依据主控制系统发布的体内视觉装置201,体外成像装置210的疾病图像,器官,破损组织的双精准定位,双精准识别方法。高精准划分正常区域及破损区域。确定划定破损区域的手术范围,投药位置范围及其坐标。依据主控制系统发布动作规划指令消息,机器人检查手术装置,机器人治疗装置订阅指令消息。The master control system publishes disease images, information on the location of damaged tissue. The robot driving module 207, radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to subscribe to the location message. The radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to guide the internal magnetic device 203 to drive the micro-robot to swim and move to the position of the damaged tissue. According to the in vivo vision device 201 and the disease images of the in vitro imaging device 210 issued by the main control system, the double accurate positioning of organs and damaged tissues, and the double accurate identification method. High-precision division of normal areas and damaged areas. Determine the scope of surgery to delineate the damaged area, the scope of the drug delivery location and its coordinates. According to the main control system, the action planning command message is issued, the robot checks the surgical device, and the robot treatment device subscribes to the command message.
进一步,所述动作规划模块,包括机器人检查手术动作规划,机器人治疗投药动作规划。Further, the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
机器人检查手术装置模块,在摄像头体内成像,及体外成像210引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度。医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置204,破损组织检查及执行手术操作,实现切割,缝合,穿刺,烧灼,电刀,激光切割,靶向治疗。The robot inspects the surgical device module, imaging in the camera body, and in vitro imaging 210 to guide the device to accurately locate the damaged tissue, and accurately divide the damaged tissue area from the normal tissue area, according to the degree of damage. The doctor remotely controls the built-in micro forceps, micro forceps, puncture and retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, laser devices and other surgical devices 204, damaged tissue inspection and operation. Operation to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
实施例4:Example 4:
如图2所示,最优化的药物确定以及其定量方法的智能计算方法实施如下:As shown in Figure 2, the optimal drug determination and the intelligent calculation method of its quantification method are implemented as follows:
确定药物以及其定量方法,监测的身体内部免疫环境的指标,肿瘤治疗微环境的指标为常量。Determining drugs and their quantification methods, monitoring the indicators of the body's internal immune environment, and the tumor treatment microenvironment are constant.
主要的治疗药物,普通药物的用量,周期为变量。建立身体内部免疫环境的数学模型,肿瘤治疗微环境最优数学模型,肿瘤治疗副作用数学模型,计算身体内部免疫环境最优。The main treatment drugs, the dosage of common drugs, and the cycle are variables. Establish the mathematical model of the internal immune environment of the body, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and calculate the optimal internal immune environment of the body.
模型变量如下:The model variables are as follows:
药品的分类:主要治疗药物(main drug mm∈{1,2,....M}) Classification of drugs: main drug (main drug m m∈{1, 2, ....M})
普通调解药物(drug nn∈{1,2,....N}) Common Mediation Drug (drug n n∈{1,2,....N})
主要疗效施药
Figure PCTCN2022000044-appb-000023
主要疗效未施药
Figure PCTCN2022000044-appb-000024
main therapeutic effect
Figure PCTCN2022000044-appb-000023
Primary efficacy not administered
Figure PCTCN2022000044-appb-000024
普通药物施药
Figure PCTCN2022000044-appb-000025
普通药物未施药
Figure PCTCN2022000044-appb-000026
General drug administration
Figure PCTCN2022000044-appb-000025
Common medicines not administered
Figure PCTCN2022000044-appb-000026
主药品的施药数量
Figure PCTCN2022000044-appb-000027
The amount of the main drug applied
Figure PCTCN2022000044-appb-000027
普通药品施药数量
Figure PCTCN2022000044-appb-000028
Quantity of common medicines applied
Figure PCTCN2022000044-appb-000028
治疗周期(t tt∈{1,2,....T}). treatment period (t t t∈{1, 2, ....T}).
治疗周期难愈参数
Figure PCTCN2022000044-appb-000029
Treatment cycle refractory parameters
Figure PCTCN2022000044-appb-000029
疾病(D dd∈{1,2,....D}). disease(D d d∈{1, 2, ....D}).
破损点数量
Figure PCTCN2022000044-appb-000030
Number of damage points
Figure PCTCN2022000044-appb-000030
破损组织区域尺寸
Figure PCTCN2022000044-appb-000031
Damaged tissue area size
Figure PCTCN2022000044-appb-000031
疾病程度/破损程度
Figure PCTCN2022000044-appb-000032
Degree of disease/damage
Figure PCTCN2022000044-appb-000032
治疗方法参数Treatment method parameters
包括主要的治疗方法(硬性治疗指标
Figure PCTCN2022000044-appb-000033
)及普通药物治疗方法
Figure PCTCN2022000044-appb-000034
Including the main treatment method (hard treatment index
Figure PCTCN2022000044-appb-000033
) and common drug treatments
Figure PCTCN2022000044-appb-000034
疾病治疗的基本的效果
Figure PCTCN2022000044-appb-000035
Basic effects of disease treatment
Figure PCTCN2022000044-appb-000035
监测指标monitor ee∈{1,2,....E},监测实时指标monitor e-realtime,监测指标标准monitor e-std Monitoring indicators monitor e e∈{1, 2, ....E}, monitoring real-time indicators monitor e-realtime , monitoring indicator standards monitor e-std
副作用监测指标monitor sub-bb∈{1,2,....B} Side effect monitoring indicator monitor sub-b b∈{1, 2, ....B}
drug n免疫效力参数
Figure PCTCN2022000044-appb-000036
drug n immune potency parameters
Figure PCTCN2022000044-appb-000036
main drug m微环境效力参数
Figure PCTCN2022000044-appb-000037
Main drug m microenvironment potency parameters
Figure PCTCN2022000044-appb-000037
main drug m肿瘤治疗副作用负面指标效力
Figure PCTCN2022000044-appb-000038
main drug m tumor treatment side effects negative indicators efficacy
Figure PCTCN2022000044-appb-000038
●身体内部免疫环境最优:●The optimal immune environment in the body:
Figure PCTCN2022000044-appb-000039
Figure PCTCN2022000044-appb-000039
●肿瘤治疗微环境最优:Optimal tumor treatment microenvironment:
Figure PCTCN2022000044-appb-000040
Figure PCTCN2022000044-appb-000040
●肿瘤治疗副作用最小:●Minimum side effects of tumor treatment:
Figure PCTCN2022000044-appb-000041
Figure PCTCN2022000044-appb-000041
●药物抵达最优:●The drug arrives optimally:
Figure PCTCN2022000044-appb-000042
Figure PCTCN2022000044-appb-000042
规划的施药数量多为放射药物,靶向药物,化疗药物等的药物。The number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
●治疗周期最短:●Shortest treatment cycle:
Figure PCTCN2022000044-appb-000043
Figure PCTCN2022000044-appb-000043
S4.制约条件包括:S4. Constraints include:
3)时间周期内的药物最大用量上限范围内3) Within the upper limit of the maximum dosage of the drug within the time period
4)药物最长使用周期范围内4) Within the longest period of use of the drug
3)用药周期标准值范围内3) Within the range of the standard value of the medication cycle
4)破损组织的区域范围内4) Within the area of damaged tissue
5)治疗期内的最大副作用的承受能力范围内5) Within the tolerance range of the maximum side effects during the treatment period
6)满足疾病的基本用药治疗疗效。6) To meet the basic drug treatment efficacy of the disease.
7)满足药物的基本用量。7) Meet the basic dosage of the drug.
S5.多目标包括:S5. Multi-target includes:
身体内部免疫环境最优,The body's internal immune environment is optimal,
肿瘤治疗微环境最优Optimal tumor treatment microenvironment
治疗副作用最小Treatment with minimal side effects
药物抵达最优The drug arrives at the best
治疗周期最短The shortest treatment period
MIN(F)MIN(F)
Figure PCTCN2022000044-appb-000044
Figure PCTCN2022000044-appb-000044
Figure PCTCN2022000044-appb-000045
Figure PCTCN2022000044-appb-000045
通过最优化方法中的一种及多种,通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗。输出不同时间周期内的用药及用药量。Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of treatment methods and drug methods, the optimal regulation of drugs and doses, accurate positioning of carcinogenic sites, specific tumor cells, drug delivery, To achieve optimal regulation of treatment. Output the medication and dosage in different time periods.
依照多目标最优化调控方法,规划放射药物(化疗药物)施药的数量,规划放射药物播种路径,返回投药路径以及各播种点位置坐标,主控制系统发布按照返回的投药路径以及各播种点位置坐标,医生远端操控以及自主控制投药装置,移动投药装置至投药的各播种点实施投药。According to the multi-objective optimization control method, plan the amount of radiopharmaceutical (chemotherapy) spraying, plan the radiopharmaceutical seeding path, return the drug delivery path and the position coordinates of each seeding point, and the main control system publishes the returned drug delivery path and the position of each seeding point. Coordinates, the doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.

Claims (10)

  1. 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,一种体内微型机器人装置包括:An in-vivo micro-robot device, an optimized treatment regulation system and method, is characterized in that, an in-vivo micro-robot device comprises:
    主控制系统,所述主控制系统用于控制体内微型机器人装置;a main control system, the main control system is used to control the in vivo micro-robot device;
    体内微型机器人装置包括:视觉识别模块,多传感模块,照明装置,体内行走驱动装置,穿刺装置,手术检查处理装置,驱动装置,软体支架,固定装置,治疗装置,精准投药装置;The in-vivo micro-robot device includes: a visual recognition module, a multi-sensing module, a lighting device, an in-vivo walking driving device, a puncture device, a surgical inspection processing device, a driving device, a soft support, a fixing device, a treatment device, and a precise drug delivery device;
    体外成像装置,用于体外成像,包括:超声成像,CT成像,红外近成像,X光成像等多种成像方式中的一种;In vitro imaging device, used for in vitro imaging, including: one of various imaging methods such as ultrasound imaging, CT imaging, infrared near imaging, and X-ray imaging;
    体内的微型摄像头及视觉识别模块,用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置;The miniature camera and visual recognition module in the body are used to collect in-vivo images, assist in the identification of damaged tissues and tumors in the body, and locate their positions;
    光,照明装置,用于体内照明,摄像检查;Light, lighting device, used for internal lighting, camera inspection;
    多传感模块,包括:微型生物传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息;Multi-sensing modules, including: one or more of a variety of sensors such as miniature biosensing, integrated gene sensing, etc., used to collect sensor information in vivo;
    驱动装置,用于驱动机器人在体内无损伤,可控速,有方向的游动;The driving device is used to drive the robot to swim without damage in the body, with controllable speed and direction;
    引导,定位,移动装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤。定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置;The guiding, positioning, and moving device is connected with the in vitro imaging device, and the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in-vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in-vivo micro-robot to locate the damaged tissue and tumor in the body. Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Carry out internal and external communication, guide the positioning of the internal robot, and move the device;
    软体支架,固定装置,用于体内游动,一时停止,破损组织,肿瘤位置手术处理时固定;Soft stent, fixation device, used for swimming in the body, temporary stop, damaged tissue, fixation of tumor location during surgical treatment;
    可伸缩的体内检查,手术处理装置,包括:微型的镊子,微型钳子,穿刺用刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种。用于体内检查,穿刺,手术操作,消融治疗;Retractable in-vivo inspection and surgical treatment devices, including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device. For internal examination, puncture, surgical operation, ablation treatment;
    可伸缩的治疗,精准投药装置,可伸缩的治疗装置,用于破损组织,药物粒子植入,放置装置,用于放射治疗,放射性粒子植入治疗;可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损组织,肿瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。Retractable treatment, precise drug delivery device, retractable treatment device, used for damaged tissue, drug particle implantation, placement device, used for radiation therapy, radioactive particle implantation therapy; retractable precise drug delivery device, used to locate damage Tissue, tumor location, calculation of damaged tissue, tumor size, degree of damage, precise drug determination, drug delivery device for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cell target drug delivery therapy, radiation therapy, radioactive seed implantation A variety of precise drug delivery treatments such as injection therapy.
  2. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,通过口腔,鼻腔,耳道,肚脐,阴道,肛门等器官,体内通过电磁,射频,磁等引导装置移动定位,减少体外手术创伤大风险高,实现基本无创伤,体内检查,手术,高效地实现了体内实时监测,最优化控制体内病情。An in vivo micro-robot device according to claim 1, characterized in that, through the oral cavity, nasal cavity, ear canal, navel, vagina, anus and other organs, the body is moved and positioned by electromagnetic, radio frequency, magnetic and other guiding devices, reducing the need for external surgery The risk of trauma is high and it is basically non-invasive. In-vivo examination and surgery can efficiently realize real-time monitoring in the body and optimize the control of the disease in the body.
  3. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,双精准的成像方式,采用微型摄像头的体内摄像头及视觉识别模块与体外成像装置协同作业,高精准采集,辅助识别器官,破损组织,肿瘤等图像,准确识别破损组织及正常组织区域;体内摄像头及视觉识别模块用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置;所述的视觉识别模块包括:微型内窥镜,微型显微镜等体内成像装置中的一 种与多种以及3D成像系统与体外成像引导装置协同作业,采集并智能识别体内多种疾病图像。An in-vivo micro-robot device according to claim 1, characterized in that, the dual-precision imaging method adopts the in-vivo camera and the visual recognition module of the micro-camera to cooperate with the in-vitro imaging device, high-precision acquisition, auxiliary identification of organs, damage to Tissue, tumor and other images, accurately identify damaged tissue and normal tissue area; in-vivo camera and visual recognition module are used to collect in-vivo images, assist in identifying damaged tissue, tumor in vivo, and locate their positions; the visual recognition module includes: micro endoscopy One of the in vivo imaging devices such as microscopes, micro microscopes, etc., as well as 3D imaging systems and in vitro imaging guidance devices, work together to collect and intelligently identify images of various diseases in the body.
  4. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,驱动装置驱动机器人在体内无损伤,可控速,有方向的游动,利用软体支架,固定装置一时性固定,辅助体内机器人实施手术,破损组织检查等完成体内治疗,利用定位,引导装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤;体内游动,驱动装置,用于驱动微型机器人体内移动,行走,游动;驱动装置包括:电流驱动,电磁驱动及磁驱动中的一种;定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置,软体支架,固定装置,用于体内组织检查,破损组织,肿瘤位置的手术处理时的固定。An in-vivo micro-robot device according to claim 1, wherein the driving device drives the robot to move in a non-damaged, speed-controlled, directional way in the body, using a soft support, the fixing device is temporarily fixed, and assists the in-vivo robot Perform surgery, damage tissue inspection, etc. to complete in vivo treatment, use positioning and guiding devices, connect with in vitro imaging devices, guide in vivo micro-robot positioning and movement through the in vitro imaging system, assist in the acquisition of in vivo images, assist in the identification of damaged tissue, tumors in vivo and guide in vivo Micro-robot locates damaged tissues and tumors in the body; in-vivo swimming, driving device is used to drive the micro-robot to move, walk and swim in vivo; the driving device includes: one of current drive, electromagnetic drive and magnetic drive; positioning and guiding device Including: RF radio frequency device (external transmitter and in vivo receiver), electromagnetic guidance device (external electromagnetic controller and in vivo micro coil and other electromagnetic devices), magnetic guidance device (external magnetic controller and in vivo micro coil), etc. for internal and external communication , Guided in vivo robot positioning, mobile device, soft support, fixation device, used for in vivo tissue inspection, damaged tissue, and fixation of tumor location during surgical treatment.
  5. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,多传感模块实时监测体内环境,多传感包括:微型生物传感,微型医疗传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息,实时监测体内环境;体内体环境包括:体内免疫环境以及肿瘤治疗微环境等治疗,监测期间的体内环境。The in-vivo micro-robot device according to claim 1, wherein the multi-sensing module monitors the in-vivo environment in real time, and the multi-sensing includes: micro bio-sensing, micro-medical sensing, integrated gene sensing, etc. One or more of the sensors are used to collect in vivo sensor information and monitor the in vivo environment in real time; the in vivo in vivo environment includes: the in vivo immune environment and the tumor treatment microenvironment, and the in vivo environment during monitoring.
  6. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,体内检查,手术处理装置。手术检查处理装置,包括:微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种,用于检查,穿刺,手术操作;通过摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,采用远端操控体内微型机器人装置内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置实现切割,缝合,穿刺,烧灼,激光切割,靶向治疗。An in-vivo micro-robot device according to claim 1, characterized in that it is an in-vivo examination and a surgical treatment device. Surgical inspection and processing devices, including: one or more of micro forceps, micro forceps, puncture retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, and laser devices, used for inspection, Puncture, surgical operation; the in vivo imaging of the camera and the in vitro imaging guide device are used to precisely locate the damaged tissue, and accurately divide the damaged tissue area and the normal tissue area. Pliers, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device for cutting, suturing, puncturing, cauterization, laser cutting, targeted therapy.
  7. 根据权利要求1所述的一种体内微型机器人装置,其特征在于,可伸缩的治疗,精准投药装置,粒子植入装置以及依照破损位置,破损区域尺寸,破损程度的药品定量最优化方法,实现精准投药,精准的靶向治疗,准确划分破损的组织区域与正常组织区域实现投药副作用最小,投药效果最优化;可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损组织,肿瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。An in-vivo micro-robot device according to claim 1, characterized in that, the retractable treatment, precise drug delivery device, particle implantation device, and a quantitative optimization method for drugs according to the damaged position, the size of the damaged area, and the degree of damage, realize Precise drug delivery, precise targeted therapy, accurate division of damaged tissue area and normal tissue area to minimize drug side effects and optimize drug delivery effect; retractable precise drug delivery device, used to locate damaged tissue, tumor location, calculate damaged tissue, The size of the tumor, the degree of damage, the precise drug setting, and the drug delivery device are used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cell target drug delivery therapy, radiotherapy, radioactive particle implantation therapy and other precise drug delivery treatments.
  8. 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,器官,破损组织的双精准定位,双精准识别方法,体内视觉装置,体外成像装置双精准识别人体器官,破损组织,划分正常区域及破损区域的高精准识别;An in-vivo micro-robot device, an optimized treatment regulation system and method, characterized in that the dual-precision positioning of organs and damaged tissues, the dual-precision identification method, the in-vivo vision device, and the in-vitro imaging device dual-precision identification of human organs, damaged tissues, division High-precision identification of normal areas and damaged areas;
    体外的成像装置及人体器官特征位置及医疗图像与显微镜,内窥镜下内部脏器识别方法,包括以下步骤:An in vitro imaging device and a characteristic position of human organs, a medical image and a microscope, and a method for recognizing internal organs under an endoscope, comprising the following steps:
    S1、建立体外成像图像及体内显微镜下的人体器官的轮廓,形状,纹理,颜色,尺寸等的特征模型;S1. Establish a characteristic model of the contour, shape, texture, color, size, etc. of human organs under in vitro imaging images and in vivo microscopes;
    S2、建立破损组织炎症,肿瘤,囊肿等多种疾病模型;S2. Establish various disease models such as damaged tissue inflammation, tumor, cyst, etc.;
    S3、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓,各器官的特征值及其对应的外部特征所对应的人体外部位置区;S3, extracting the in vitro imaging image and the internal contour of the image organ under the in vivo microscope, the feature value of each organ and the external position area of the human body corresponding to the corresponding external feature;
    S4、输入体外成像图像及体内显微镜下的图像的各器官外部特征值所对应的人体内部器官图像的特征值,改进深度神经网络方法及权值优化器,通过图像训练,得到输出值及内部器官分类,器官识别结果;S4. Input the eigenvalues of the human internal organ images corresponding to the external eigenvalues of each organ of the in vitro imaging image and the image under the in vivo microscope, improve the deep neural network method and the weight optimizer, and obtain the output values and internal organs through image training Classification, organ identification results;
    S5、输出结果,精准分类,识别体外成像及体内显微镜下的人体器官图像;S5. Output results, accurately classify, and identify human organ images under in vitro imaging and in vivo microscopes;
    机器人双图像匹配,定位,精准划分破损组织的疾病位置及正常组织的方法,包括以下步骤:The method of robot double image matching, positioning, and accurately dividing the diseased position of damaged tissue and normal tissue, including the following steps:
    S1、微型机器人发布体内显微镜下图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标;S1. The micro-robot publishes the position area of the organ and its coordinate boundary in the image under the in vivo microscope, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates;
    S2、体外成像系统模块发布体外成像图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标;S2. The in vitro imaging system module publishes the position area of the organ and its coordinate boundary of the in vitro imaging image, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates;
    S3、利用坐标转换方法,建立机器人主控制系统下双图像的坐标参照转换,各器官的双图像下的器官及其坐标位置匹配;S3. Use the coordinate transformation method to establish the coordinate reference transformation of the dual images under the main control system of the robot, and match the organs and their coordinate positions under the dual images of each organ;
    S4、建立体内显微镜下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型;S4. Establish a model of various diseases such as inflammation, tumor, cyst and other diseases of damaged tissue images under the in vivo microscope;
    S5、建立体外成像系统下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型;S5. Establish models of various diseases such as inflammation, tumors, cysts and other diseases in damaged tissue images under the in vitro imaging system;
    S6、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓及其疾病模型下的特征值及其对应的位置区,位置坐标;S6, extracting the in vitro imaging image and the internal contour of the image organ under the in vivo microscope and the eigenvalues under the disease model and its corresponding position area and position coordinates;
    S7、利用改进的神经网络方法及权值优化器,识别双系统图像下的疾病,标注并画出双图像下的疾病位置区域,尺寸,返回位置坐标;S7. Use the improved neural network method and weight optimizer to identify the disease under the dual-system image, label and draw the disease location area and size under the dual-image, and return the position coordinates;
    S8、智能识别模块输出疾病种类,疾病器官及其器官下异常病症的位置区域,返回其识别结果至主控制系统。S8. The intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
  9. 一种机器人装置、最优化控制系统、方法,其特征在于,采用最优化的方法调控药物及治疗方法。药物调控包括:药物选择,药物的用量,药物的周期;调控治疗方法包括:体内手术,普通药物精准治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式,设定多种治疗的综合指标为多目标,最优化调控治疗方案;其中,最优化的方法包括:遗传计算方法及其改进方法,禁忌搜索计算方法及其改进方法,模拟退火计算方法及其改进方法,蚁群计算方法及其改进方法,粒子束最优化的计算方法及其改进方法,神经网络计算方法及其改进方法,进化方法及其改进方法,中的一种及多种;通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗,调控的具体步骤如下:A robotic device, an optimal control system, and a method, characterized in that an optimal method is used to regulate medicines and treatment methods. Drug regulation includes: drug selection, drug dosage, and drug cycle; regulatory treatment methods include: internal surgery, precision treatment with common drugs, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy and other treatment methods. The comprehensive index of the treatment is multi-objective, and the optimal regulation and treatment plan; wherein, the optimization methods include: genetic computing method and its improvement method, tabu search calculation method and its improvement method, simulated annealing calculation method and its improvement method, ant One or more of swarm computing method and its improvement method, particle beam optimization calculation method and its improvement method, neural network calculation method and its improvement method, evolutionary method and its improvement method; The combination of real-time dynamic adjustment of treatment methods and drug methods can optimize and control drugs and doses, accurately locate carcinogenic sites, specific tumor cells, and administer drugs to achieve optimal control and treatment. The specific steps of control are as follows:
    S1.监测的身体内部免疫环境的指标,肿瘤治疗微环境的指标为常量;S1. The indicators of the immune environment within the body to be monitored, and the indicators of the tumor treatment microenvironment are constant;
    身体内部免疫环境最优---监测指标与标准指标差的绝对值*权值的总和;The optimal immune environment in the body---the absolute value of the difference between the monitoring index and the standard index * the sum of the weights;
    肿瘤治疗微环境最优-----监测指标与标准指标差的绝对值*权值的总和;The optimal tumor treatment microenvironment—the absolute value of the difference between the monitoring index and the standard index * the sum of the weights;
    S2.主要的治疗方法(体内手术,普通药物精准治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式)S2. The main treatment methods (in vivo surgery, precision medicine treatment, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy, etc.)
    以及普通药物治疗的药物选择,药物用量,时间周期为变量;As well as drug selection, drug dosage, and time period for common drug therapy are variables;
    S3.分别建立身体内部免疫环境的数学模型,肿瘤治疗微环境最优数学模型,肿瘤治疗副作用数学模型,药物抵达数学模型如下:S3. Establish the mathematical model of the body's internal immune environment, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and the mathematical model of drug arrival as follows:
    变量:variable:
    药品的分类:主要治疗药物(main drug m m∈{1,2,....M}) Classification of drugs: main drug (main drug m m∈{1, 2, ....M})
    普通调解药物(drug nn∈{1,2,....N}) Common Mediation Drug (drug n n∈{1,2,....N})
    主要疗效施药
    Figure PCTCN2022000044-appb-100001
    主要疗效未施药
    Figure PCTCN2022000044-appb-100002
    main therapeutic effect
    Figure PCTCN2022000044-appb-100001
    Primary efficacy not administered
    Figure PCTCN2022000044-appb-100002
    普通药物施药
    Figure PCTCN2022000044-appb-100003
    普通药物未施药
    Figure PCTCN2022000044-appb-100004
    General drug administration
    Figure PCTCN2022000044-appb-100003
    Common medicines not administered
    Figure PCTCN2022000044-appb-100004
    主药品的施药数量
    Figure PCTCN2022000044-appb-100005
    The amount of the main drug applied
    Figure PCTCN2022000044-appb-100005
    普通药品施药数量
    Figure PCTCN2022000044-appb-100006
    Quantity of common medicines applied
    Figure PCTCN2022000044-appb-100006
    治疗周期(t tt∈{1,2,....T}), treatment period (t t t∈{1, 2, ....T}),
    治疗周期难愈参数
    Figure PCTCN2022000044-appb-100007
    Treatment cycle refractory parameters
    Figure PCTCN2022000044-appb-100007
    疾病(D dd∈{1,2,....D}), disease(D d d∈{1,2,....D}),
    破损点数量
    Figure PCTCN2022000044-appb-100008
    Number of damage points
    Figure PCTCN2022000044-appb-100008
    破损组织区域尺寸
    Figure PCTCN2022000044-appb-100009
    Damaged tissue area size
    Figure PCTCN2022000044-appb-100009
    疾病程度/破损程度
    Figure PCTCN2022000044-appb-100010
    Degree of disease/damage
    Figure PCTCN2022000044-appb-100010
    治疗方法参数Treatment method parameters
    包括主要的治疗方法(硬性治疗指标
    Figure PCTCN2022000044-appb-100011
    )及普通药物治疗方法
    Figure PCTCN2022000044-appb-100012
    Including the main treatment method (hard treatment index
    Figure PCTCN2022000044-appb-100011
    ) and common drug treatments
    Figure PCTCN2022000044-appb-100012
    疾病治疗的基本的效果
    Figure PCTCN2022000044-appb-100013
    Basic effects of disease treatment
    Figure PCTCN2022000044-appb-100013
    监测指标monitor ee∈{1,2,....E},监测实时指标monitor e-realtime,监测指标标准monitor e-std Monitoring indicators monitor e e∈{1, 2, ....E}, monitoring real-time indicators monitor e-realtime , monitoring indicator standards monitor e-std
    副作用监测指标monitor sub-bb∈{1,2,....B}; Side effect monitoring indicator monitor sub-b b∈{1, 2, ....B};
    drug n免疫效力参数
    Figure PCTCN2022000044-appb-100014
    drug n immune potency parameters
    Figure PCTCN2022000044-appb-100014
    main drug m微环境效力参数
    Figure PCTCN2022000044-appb-100015
    Main drug m microenvironment potency parameters
    Figure PCTCN2022000044-appb-100015
    main drug m肿瘤治疗副作用负面指标效力
    Figure PCTCN2022000044-appb-100016
    main drug m tumor treatment side effects negative indicators efficacy
    Figure PCTCN2022000044-appb-100016
    ●身体内部免疫环境最优:●The optimal immune environment in the body:
    Figure PCTCN2022000044-appb-100017
    Figure PCTCN2022000044-appb-100017
    ●肿瘤治疗微环境最优:Optimal tumor treatment microenvironment:
    Figure PCTCN2022000044-appb-100018
    Figure PCTCN2022000044-appb-100018
    ●肿瘤治疗副作用最小:●Minimum side effects of tumor treatment:
    Figure PCTCN2022000044-appb-100019
    Figure PCTCN2022000044-appb-100019
    ●药物抵达最优:●The drug arrives optimally:
    Figure PCTCN2022000044-appb-100020
    Figure PCTCN2022000044-appb-100020
    规划的施药数量多为放射药物,靶向药物,化疗药物等的药物;The number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs, etc.;
    ●治疗周期最短:●Shortest treatment cycle:
    Figure PCTCN2022000044-appb-100021
    Figure PCTCN2022000044-appb-100021
    S4.制约条件包括:S4. Constraints include:
    1)时间周期内的药物最大用量上限范围内1) Within the upper limit of the maximum dosage of the drug within the time period
    2)药物最长使用周期范围内2) Within the longest period of use of the drug
    3)用药周期标准值范围内3) Within the range of the standard value of the medication cycle
    4)破损组织的区域范围内4) Within the area of damaged tissue
    5)治疗期内的最大副作用的承受能力范围内5) Within the tolerance range of the maximum side effects during the treatment period
    6)满足疾病的基本用药治疗疗效6) Satisfy the efficacy of the basic drug treatment for the disease
    7)满足药物的基本用量7) Meet the basic dosage of the drug
    S5.多目标包括:S5. Multi-target includes:
    身体内部免疫环境最优,The body's internal immune environment is optimal,
    肿瘤治疗微环境最优,The optimal tumor treatment microenvironment,
    治疗副作用最小,Treatment with minimal side effects,
    药物抵达最优,The drug arrives at the best,
    治疗周期最短,The shortest treatment period,
    MIN(F)MIN(F)
    Figure PCTCN2022000044-appb-100022
    Figure PCTCN2022000044-appb-100022
    Figure PCTCN2022000044-appb-100023
    Figure PCTCN2022000044-appb-100023
    S6.通过最优化方法中的一种及多种,通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗;S6. Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of the treatment method and drug method, the drug is optimally regulated, the amount of the drug, the precise positioning of the carcinogenic site, the specific tumor cell, and the delivery. Drugs to achieve optimal regulation and treatment;
    S7.输出不同时间周期内的用药及用药量。S7. Output the medication and the amount of medication in different time periods.
  10. 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,一种高精准定位,远端控制的无创体内手术方法以及远端及自主的投药方法,所述方法包括以下步骤:An in-vivo micro-robot device, an optimized treatment regulation system and method, characterized in that a non-invasive in-vivo surgical method with high-precision positioning and remote control, and a remote and autonomous drug administration method, the method comprises the following steps:
    S1、主控制系统发布疾病图像,破损组织的位置消息;S1. The main control system publishes disease images and location information of damaged tissues;
    S2、机器人驱动模块,射频接收器或电磁引导自主定位移动模块订阅位置消息;S2. The robot drive module, the radio frequency receiver or the electromagnetic guided autonomous positioning mobile module subscribes to the location message;
    S3、射频接收器或电磁引导磁引导自主定位移动模块引导体内磁装置驱动微型机器人游动,移动至破损组织的位置;S3. The radio frequency receiver or the electromagnetic guided magnetic guided autonomous positioning and moving module guides the internal magnetic device to drive the micro-robot to swim and move to the position of the damaged tissue;
    S4、依据主控制系统发布的体内视觉装置,体外成像装置的疾病图像,依据权利要求7所述的器官,破损组织的双精准定位,双精准识别方法,高精准划分正常区域及破损区域;S4. According to the in-vivo vision device and the disease image of the in-vitro imaging device released by the main control system, according to the organ according to claim 7, double-precision positioning of damaged tissue, double-precision identification method, high-precision division of normal area and damaged area;
    S5、确定划定破损区域的手术范围,投药位置范围及其坐标;S5. Determine the scope of surgery to delineate the damaged area, the scope of the drug administration position and its coordinates;
    S6、依据主控制系统发布动作规划指令消息,机器人检查手术装置,机器人治疗装置订阅指令消息。S6. According to the main control system, the action planning instruction message is released, the robot checks the surgical device, and the robot treatment device subscribes to the instruction message.
    进一步,所述动作规划模块,包括机器人检查手术动作规划,机器人治疗投药动作规划;Further, the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan;
    S7、步骤S6中,所述的机器人检查手术装置模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置,破损组织检查及执行手术操作,实现切割,缝合,穿刺,烧灼,电刀,激光切割,靶向治疗;S7. In step S6, the robot inspects the surgical device module, images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, accurately divides the damaged tissue area and the normal tissue area, and according to the degree of damage, the doctor remotely controls the body Micro-robot built-in micro forceps, micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device and other surgical devices, damaged tissue inspection and performing surgical operations, realize cutting, suturing , puncture, cautery, electrosurgery, laser cutting, targeted therapy;
    S8、步骤S6中,所述的机器人治疗投药动作规划模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度;S8. In step S6, the robot treatment and drug administration action planning module is used for imaging in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area, according to the degree of damage;
    S9、利用权利要求9所述的治疗综合指标多目标最优化调控方法,规划放射药物(化疗药物)施药的数量,规划放射药物播种路径,返回投药路径以及各播种点位置坐标;S9, using the multi-objective optimization control method for comprehensive treatment indicators according to claim 9, planning the quantity of radiopharmaceuticals (chemotherapeutic drugs) sprayed, planning the radiopharmaceutical seeding path, returning the drug delivery path and the position coordinates of each seeding point;
    S10、主控制系统发布按照返回的投药路径以及各播种点位置坐标,医生远端操控以及自主控制投药。S10, the main control system issues the doctor's remote control and autonomous control of the drug administration according to the returned drug administration path and the position coordinates of each seeding point.
PCT/CN2022/000044 2021-03-29 2022-03-18 Miniature in-vivo robot device, and optimal treatment regulation and control system and method WO2022206083A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022252507A AU2022252507A1 (en) 2021-03-29 2022-03-18 Miniature in-vivo robot device, and optimal treatment regulation and control system and method
CN202280024177.8A CN117545443A (en) 2021-03-29 2022-03-18 In-vivo micro-robot device, and optimized treatment regulation and control system and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110343943.4 2021-03-29
CN202110343943.4A CN113100690A (en) 2021-03-29 2021-03-29 In-vivo micro-robot device, and optimized treatment regulation and control system and method

Publications (1)

Publication Number Publication Date
WO2022206083A1 true WO2022206083A1 (en) 2022-10-06

Family

ID=76712986

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/000044 WO2022206083A1 (en) 2021-03-29 2022-03-18 Miniature in-vivo robot device, and optimal treatment regulation and control system and method

Country Status (3)

Country Link
CN (2) CN113100690A (en)
AU (1) AU2022252507A1 (en)
WO (1) WO2022206083A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113100690A (en) * 2021-03-29 2021-07-13 谈斯聪 In-vivo micro-robot device, and optimized treatment regulation and control system and method
TWI829095B (en) * 2022-02-15 2024-01-11 國立成功大學 Microrobot and manufacturing method thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050029978A1 (en) * 2003-07-08 2005-02-10 Dmitry Oleynikov Microrobot for surgical applications
US20060119304A1 (en) * 2003-07-08 2006-06-08 Shane Farritor Robot for surgical applications
CN101351141A (en) * 2005-12-27 2009-01-21 奥林巴斯株式会社 Encapsulated medical device guiding system and its control method
CN202136314U (en) * 2011-07-21 2012-02-08 长沙学院 Human intracavity tiny canal-oriented microrobot
US20130282173A1 (en) * 2012-04-20 2013-10-24 Erhan H. Gunday Remotely Controlled Surgical Robots
CN103405209A (en) * 2013-07-17 2013-11-27 南京航空航天大学 Intra-individual peristaltic detection and treatment all-in-one robot
US20160346048A1 (en) * 2011-03-22 2016-12-01 Corindus, Inc. Robotic catheter system including imaging system control
CN108837286A (en) * 2018-05-04 2018-11-20 清华大学 Degradable diagnosis and treatment robot
CN109419557A (en) * 2017-08-27 2019-03-05 南京乐朋电子科技有限公司 A kind of microrobot for interior therapeutic
CN113100690A (en) * 2021-03-29 2021-07-13 谈斯聪 In-vivo micro-robot device, and optimized treatment regulation and control system and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324451B2 (en) * 2017-06-26 2022-05-10 Bruce Reiner Nanobots with embedded biosensors
WO2018144636A1 (en) * 2017-02-01 2018-08-09 Intuitive Surgical Operations, Inc. Systems and methods of registration for image-guided procedures

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050029978A1 (en) * 2003-07-08 2005-02-10 Dmitry Oleynikov Microrobot for surgical applications
US20060119304A1 (en) * 2003-07-08 2006-06-08 Shane Farritor Robot for surgical applications
CN101351141A (en) * 2005-12-27 2009-01-21 奥林巴斯株式会社 Encapsulated medical device guiding system and its control method
US20160346048A1 (en) * 2011-03-22 2016-12-01 Corindus, Inc. Robotic catheter system including imaging system control
CN202136314U (en) * 2011-07-21 2012-02-08 长沙学院 Human intracavity tiny canal-oriented microrobot
US20130282173A1 (en) * 2012-04-20 2013-10-24 Erhan H. Gunday Remotely Controlled Surgical Robots
CN103405209A (en) * 2013-07-17 2013-11-27 南京航空航天大学 Intra-individual peristaltic detection and treatment all-in-one robot
CN109419557A (en) * 2017-08-27 2019-03-05 南京乐朋电子科技有限公司 A kind of microrobot for interior therapeutic
CN108837286A (en) * 2018-05-04 2018-11-20 清华大学 Degradable diagnosis and treatment robot
CN113100690A (en) * 2021-03-29 2021-07-13 谈斯聪 In-vivo micro-robot device, and optimized treatment regulation and control system and method

Also Published As

Publication number Publication date
CN117545443A (en) 2024-02-09
AU2022252507A1 (en) 2023-11-16
CN113100690A (en) 2021-07-13

Similar Documents

Publication Publication Date Title
WO2022206083A1 (en) Miniature in-vivo robot device, and optimal treatment regulation and control system and method
US11571258B2 (en) Path planning method with artificial potential field based on obstacle classification and medical system for steering flexible needle
EP1396233B1 (en) Positioning system for neurological procedures in the brain
CN102319117B (en) Arterial intervention implant implanting system capable of fusing real-time ultrasonic information based on magnetic navigation
US20100268072A1 (en) Method and apparatus for positional tracking of therapeutic ultrasound transducer
JP2021502195A (en) Robotic equipment for minimally invasive medical interventions in soft tissues
US20120281898A1 (en) Method of identification of an element in two or more images
CN107847278A (en) Optics targets and track visualization
CN109077801B (en) Diagnosis and treatment method and system for multi-source information guided laser ablation
CN110327016A (en) Intelligent minimally invasive diagnosis and treatment integral system based on optical image and optical therapeutic
CN112022348A (en) Puncture ablation intraoperative navigation system under CT and AI dual guidance
Kaur How Medical Robots are going to Affect Our Lives: Pushing frontiers with the first lady of emerging technologies
Yin et al. Open thoracic surgical implantation of cardiac pacemakers in rats
WO2022133054A1 (en) Tissue interface system
CN105435378A (en) Focusing ultrasonic treatment system
CN109011222A (en) Body surface positioning guide plate for guiding radioactive particles to perform brachytherapy on cancer and manufacturing method
Narula et al. Future prospects of artificial intelligence in robotics software, a healthcare perspective
CN110464456B (en) Automatic laser treatment robot
WO2022199198A1 (en) Intravascular nano robot apparatus, optimized control system, and method
Ibrahim et al. Robot-assisted for medical surgery: A literature review
Garg et al. Equipment planning
CN116712163B (en) Robot system for performing radio frequency ablation operation
CN209490085U (en) Apparats for treating tumor
CN219021459U (en) Interventional needle and interventional system
Shaikh Robotic Imaging

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22778272

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2023550256

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 202280024177.8

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2022252507

Country of ref document: AU

Ref document number: AU2022252507

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2022778272

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022778272

Country of ref document: EP

Effective date: 20231030

ENP Entry into the national phase

Ref document number: 2022252507

Country of ref document: AU

Date of ref document: 20220318

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: JP

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01/03/2024)